lithium has been researched along with 1-naphthylamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, K; Bindman, J; Jennings, AL; Phillips, J; Seth, R | 1 |
| Harrington, DP; Workman, EA | 1 |
| Apseloff, G; Gerber, N; Henry, EB; Lazar, JD; Tremaine, LM; von Deutsch, DA; Wilner, KD | 1 |
| Byerly, MJ; Christensen, RC; Evans, OL | 1 |
| Rush, AJ; Suppes, T | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Cowen, PJ; McTavish, SF; Williamson, DJ | 1 |
| Byrne, S; Rothschild, AJ | 1 |
1 review(s) available for lithium and 1-naphthylamine
| Article | Year |
|---|---|
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
1 trial(s) available for lithium and 1-naphthylamine
| Article | Year |
|---|---|
Sertraline does not alter steady-state concentrations or renal clearance of lithium in healthy volunteers.
Topics: 1-Naphthylamine; Adolescent; Adult; Humans; Kidney; Lithium; Male; Metabolic Clearance Rate; Sertraline; Tremor | 1992 |
6 other study(ies) available for lithium and 1-naphthylamine
| Article | Year |
|---|---|
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.
Topics: 1-Naphthylamine; Adult; Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Nortriptyline; Receptors, Adrenergic; Receptors, Serotonin; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
Sertraline-augmented lithium therapy of organic mood syndrome.
Topics: 1-Naphthylamine; Brain Injuries; Female; Hospitalization; Humans; Lithium; Middle Aged; Neurocognitive Disorders; Serotonin Receptor Agonists; Sertraline | 1992 |
Delirium associated with a combination of sertraline, haloperidol, and benztropine.
Topics: 1-Naphthylamine; Adult; Benztropine; Delirium; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Medication optimization during clozapine treatment.
Topics: 1-Naphthylamine; Adult; Clozapine; Drug Therapy, Combination; Humans; Lithium; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Valproic Acid | 1996 |
Effect of valine on 5-HT neurotransmission and mood.
Topics: 1-Naphthylamine; Adult; Affect; Amino Acids, Branched-Chain; Amitriptyline; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fenfluramine; Humans; Lithium; Male; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Valine | 1996 |
Psychiatrists' responses to failure of maintenance therapy with antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Attitude of Health Personnel; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Nortriptyline; Recurrence; Sertraline; Treatment Failure | 1997 |